Impact of dyslipidemia in the development of cardiovascular complications: Delineating the potential therapeutic role of coenzyme Q10
Abstract
No abstract availableKeywords
Funding Information
- South African Medical Research Council
- National Treasury
- National Research Foundation
This publication has 89 references indexed in Scilit:
- The effects of statins on the mevalonic acid pathway in recombinant yeast strains expressing human HMG-CoA reductaseBMC Biotechnology, 2013
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for managementEuropean Heart Journal, 2011
- Oxidative Stress and Diabetic ComplicationsCirculation Research, 2010
- Coenzyme Q – Biosynthesis and functionsBiochemical and Biophysical Research Communications, 2010
- Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic OpportunitiesAntioxidants & Redox Signaling, 2010
- The Role of Mitochondria in the Pathophysiology of Skeletal Muscle Insulin ResistanceEndocrine Reviews, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Coenzyme Q, oxidative stress and agingMitochondrion, 2007
- The Role of Coenzyme Q10 in Statin-Associated MyopathyJACC, 2007
- Effect of combined coenzyme Q10 and d-α-tocopheryl acetate supplementation on exercise-induced lipid peroxidation and muscular damage: a placebo-controlled double-blind study in marathon runnersFree Radical Research, 1998